Navco Pharmaceuticals (FRA:F0U) EV-to-OCF: -11.06 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Navco Pharmaceuticals EV-to-OCF?

Navco Pharmaceuticals FRA:F0U EV-to-OCF is -11.06 as of Sep. 16, 2026.

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Navco Pharmaceuticals's Enterprise Value is €0.18 Mil. Navco Pharmaceuticals's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.02 Mil. Therefore, Navco Pharmaceuticals's EV-to-OCF for today is -11.06.

The historical rank and industry rank for Navco Pharmaceuticals's EV-to-OCF or its related term are showing as below:

FRA:F0U's EV-to-OCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 10.12
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-09-16), Navco Pharmaceuticals's stock price is €0.001. Navco Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.001. Therefore, Navco Pharmaceuticals's PE Ratio (TTM) for today is At Loss.

Navco Pharmaceuticals  (FRA:F0U) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Navco Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.001/-0.001
=At Loss

Navco Pharmaceuticals's share price for today is €0.001.
Navco Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Navco Pharmaceuticals EV-to-OCF Related Terms

Navco Pharmaceuticals EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Navco Pharmaceuticals's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navco Pharmaceuticals EV-to-OCF Chart

Navco Pharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21
EV-to-OCF
-13.97 -3.16 0.00

Navco Pharmaceuticals Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.74 -4.97 -25.36 -23.39 -10.45

Navco Pharmaceuticals EV-to-OCF Calculation

Navco Pharmaceuticals's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.177/-0.016
=-11.06

Navco Pharmaceuticals's current Enterprise Value is €0.18 Mil.
Navco Pharmaceuticals's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-OCF →
What does a EV-to-OCF of -11.06 mean?
Navco Pharmaceuticals (FRA:F0U) has a EV-to-OCF of -11.06 as of Sep. 16, 2026.
Is Navco Pharmaceuticals' EV-to-OCF too high?
Navco Pharmaceuticals' current EV-to-OCF is -11.06.
How does Navco Pharmaceuticals' EV-to-OCF compare to ZTS and VTRS?
Navco Pharmaceuticals' EV-to-OCF of -11.06 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-OCF is 10.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.12, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Navco Pharmaceuticals's current EV-to-OCF is -11.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Navco Pharmaceuticals stock overvalued right now?
Navco Pharmaceuticals (FRA:F0U) has a current EV-to-OCF of -11.06. The current EV-to-OCF is -11.06. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Navco Pharmaceuticals (FRA:F0U), the current EV-to-OCF is -11.06 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navco Pharmaceuticals Business Description

Address 1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7
Navco Pharmaceuticals Inc is engaged in creating nanotechnology products using computer algorithms. The products are used in various industries like medicine, textiles, chemicals, and additives to combat microorganisms such as viruses and bacteria. Its products include aerosol sprays, hand cleansers, hand creams, and nano BioGuard(tm)-Silver.